OA
| |
ORBIMED ADVISORS LLC13F | |
| ORBIMED ADVISORS LLC | |
| Last update 2025-07-02 | 111 Stocks (11 new) |
| Value $4.20 Bil | Turnover 12 % |
ORBIMED ADVISORS LLC Profile
Orbimed Advisors is an investment company that was founded in 1989 with a vision to “invest across the spectrum of healthcare companies from venture capital start-ups to large multinational companies.” The company started with its first public equity fund in 1989 and would expand to offer long/short equity and private equity investments by 1993. The company would continue to grow and expand, opening its Mumbai and Shanghai offices in Asia in 2007 and beginning its international expansion. In 2010, Orbimed Advisors would expand to the Middle East, opening an office in Israel. The company would then launch its first health care royalties and credit opportunities fund in 2011 and another royalty opportunities fund in 2015. Orbimed Advisors currently has approximately $15 billion in total assets under management spread across 5 accounts, all of which are discretionary. While its number of accounts has remained relatively steady in recent years, its total assets under management has increased significantly, growing from $1.2 billion back in 2010 to over 10 times that amount today.
ORBIMED ADVISORS LLC Top Holdings of 2025-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVA | Sinovac Biotech Ltd | 2,718,735 | 333,996.6 | 0% | 7.960 | 0% | 3.780 | -113.33% | -113.33% | 460.3 | Biotechnology | |
EWTX | Edgewise Therapeutics Inc | 15,021,721 | 330,477.9 | 0% | 7.880 | 0% | 14.280 | -2.97% | -46.10% | 1,513.8 | Biotechnology | |
BSX | Boston Scientific Corp | 2,813,200 | 283,795.6 | -10.98% | 6.770 | -0.64% | 0.190 | +8.94% | +20.64% | 159,425.1 | Medical Devices & Instruments | |
LLY | Eli Lilly and Co | 337,600 | 278,827.2 | 0% | 6.650 | 0% | 0.040 | -3.48% | +3.87% | 717,192.0 | Drug Manufacturers | |
ELVN | Enliven Therapeutics Inc | 7,959,538 | 156,643.7 | 0% | 3.730 | 0% | 16.220 | +25.77% | -0.67% | 1,318.4 | Biotechnology | |
ISRG | Intuitive Surgical Inc | 291,000 | 144,123.6 | -27.56% | 3.440 | -1.19% | 0.080 | +2.87% | -3.83% | 179,937.3 | Medical Devices & Instruments | |
SYK | Stryker Corp | 359,200 | 133,712.2 | +4.30% | 3.190 | +0.13% | 0.090 | +12.51% | +11.85% | 153,221.4 | Medical Devices & Instruments | |
ARGX | argenx SE | 206,700 | 122,338.5 | +8.96% | 2.920 | +0.24% | 0.340 | -3.23% | -6.44% | 35,093.0 | Biotechnology | |
EW | Edwards Lifesciences Corp | 1,532,000 | 111,039.4 | +33.76% | 2.650 | +0.67% | 0.260 | +9.15% | +3.89% | 45,115.4 | Medical Devices & Instruments | |
UNH | UnitedHealth Group Inc | 201,200 | 105,378.5 | +53.71% | 2.510 | +0.88% | 0.020 | -31.16% | -41.52% | 265,347.7 | Healthcare Plans |
ORBIMED ADVISORS LLC's Historical Top Holdings Breakdowns
ORBIMED ADVISORS LLC's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
SRPT | Sarepta Therapeutics Inc | 2025-03-31 | Sold Out Sold Out | -2.41% | 63.82 ($105.27) 127.89 | $13.32 | -87.35% | Sold Out | 0 | -963,400 | |
PFE | Pfizer Inc | 2025-03-31 | New Buy New Buy | +2.33% | 25.01 ($26.17) 27.13 | $25.36 | -3.10% | New holding | 3,850,200 | 3,850,200 | |
MRK | Merck & Co Inc | 2025-03-31 | Sold Out Sold Out | -1.70% | 83.01 ($93.37) 101.02 | $83.98 | -10.06% | Sold Out | 0 | -829,900 | |
BIIB | Biogen Inc | 2025-03-31 | Sold Out Sold Out | -1.60% | 133.43 ($142.96) 153.27 | $130.98 | -8.38% | Sold Out | 0 | -509,100 | |
ISRG | Intuitive Surgical Inc | 2025-03-31 | Reduce Reduce | -1.19% | 476.78 ($553.02) 610.45 | $501.95 | -9.23% | Reduce -27.56% | 291,000 | -110,700 | |
AXSM | Axsome Therapeutics Inc | 2025-03-31 | New Buy New Buy | +1.08% | 80.05 ($113.93) 137.75 | $106.36 | -6.64% | New holding | 386,700 | 386,700 | |
UHS | Universal Health Services Inc | 2025-03-31 | Sold Out Sold Out | -0.99% | 163.99 ($182.38) 193.27 | $164.82 | -9.63% | Sold Out | 0 | -269,300 | |
SION | Sionna Therapeutics Inc | 2025-03-31 | New Buy New Buy | +0.92% | 0 ($15.65) 22.24 | $19.77 | 26.33% | New holding | 3,704,959 | 3,704,959 | |
UNH | UnitedHealth Group Inc | 2025-03-31 | Add Add | +0.88% | 461.52 ($511.2) 548.18 | $292.51 | -42.78% | Add 53.71% | 201,200 | 70,300 | |
THC | Tenet Healthcare Corp | 2025-03-31 | Reduce Reduce | -0.85% | 119.51 ($131.69) 144.98 | $158.31 | 20.21% | Reduce -41.29% | 465,000 | -327,000 |
ORBIMED ADVISORS LLC Total Holding History ($B)
ORBIMED ADVISORS LLC's Asset Allocation
ORBIMED ADVISORS LLC Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
ORBIMED ADVISORS LLC's Hypothetical Growth since 2025-03-31
ORBIMED ADVISORS LLC's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
ORBIMED ADVISORS LLC's Holdings Heat Map
Size field:
ORBIMED ADVISORS LLC's Holdings Bubble Chart
ORBIMED ADVISORS LLC News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers